- Home
- FTAIM vs VANI Comparison
FTAIM vs VANI Comparison
Compare FTAIM & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FTAIM
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
Current Price
Company Overview
Basic Information| Metric | FTAIM | VANI |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | 580 | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 81.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FTAIM | VANI |
|---|---|---|
| Price | $26.80 | $1.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | N/A | ★ 170.6K |
| Earning Date | N/A | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $0.91 |
| 52 Week High | N/A | $1.92 |
Technical Indicators
Market Signals| Indicator | FTAIM | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 45.69 |
| Support Level | $26.80 | $1.25 |
| Resistance Level | $27.02 | $1.55 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 40.80 | 15.91 |
Price Performance
Historical ComparisonAbout FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.